Resonance Health Management
Management criteria checks 2/4
Resonance Health's CEO is Andrew Harrison, appointed in Jul 2023, has a tenure of 1.42 years. total yearly compensation is A$526.02K, comprised of 65.1% salary and 34.9% bonuses, including company stock and options. directly owns 1.74% of the company’s shares, worth A$424.00K. The average tenure of the management team and the board of directors is 1.3 years and 8.1 years respectively.
Key information
Andrew Harrison
Chief executive officer
AU$526.0k
Total compensation
| CEO salary percentage | 65.1% |
| CEO tenure | 1.4yrs |
| CEO ownership | 1.7% |
| Management average tenure | 1.3yrs |
| Board average tenure | 8.1yrs |
Recent management updates
Recent updates
We're Interested To See How Resonance Health (ASX:RHT) Uses Its Cash Hoard To Grow
Mar 12
Resonance Health (ASX:RHT) Is In A Good Position To Deliver On Growth Plans
Aug 19Are Robust Financials Driving The Recent Rally In Resonance Health Limited's (ASX:RHT) Stock?
Mar 01If You Had Bought Resonance Health (ASX:RHT) Stock Three Years Ago, You Could Pocket A 855% Gain Today
Jan 15How Does Resonance Health's (ASX:RHT) CEO Salary Compare to Peers?
Nov 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$526k | AU$342k | AU$169k |
Compensation vs Market: Andrew's total compensation ($USD328.99K) is about average for companies of similar size in the Australian market ($USD291.73K).
Compensation vs Earnings: Insufficient data to compare Andrew's compensation with company performance.
CEO
Andrew Harrison (53 yo)
1.4yrs
Tenure
AU$526,018
Compensation
Mr. Andrew Duncan Harrison, BCom (Hons), MAICD was the Managing Director and Chief Executive Officer of Capitol Health Limited since November 11, 2016 until June 30, 2019. He serves as Chief Executive Offi...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 1.4yrs | AU$526.02k | 1.74% A$ 424.0k | |
| Chief Financial Officer | 1.2yrs | AU$367.08k | no data | |
| Company Secretary & Non Executive Director | 2.7yrs | AU$322.33k | 0.48% A$ 117.7k | |
| General Manager of People & Culture | less than a year | no data | no data | |
| Chief Scientific Officer – Imaging & AI | no data | no data | no data | |
| Chief Scientific Officer of Molecular | no data | no data | no data |
1.3yrs
Average Tenure
Experienced Management: RHT's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Company Secretary & Non Executive Director | 6.8yrs | AU$322.33k | 0.48% A$ 117.7k | |
| Non-Executive Director | 15.2yrs | AU$44.40k | 16.28% A$ 4.0m | |
| Independent Non-Executive Director | 8.1yrs | AU$44.40k | 0.25% A$ 59.9k | |
| Independent Non-Executive Chairman | 17.2yrs | AU$66.60k | 1.41% A$ 342.6k | |
| Non-Executive & Independent Director | 1.8yrs | AU$44.40k | 0.065% A$ 15.9k |
8.1yrs
Average Tenure
Experienced Board: RHT's board of directors are considered experienced (8.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 02:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Resonance Health Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|